Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Bradley Martin

Concepts (373)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Analgesics, Opioid
43
2024
590
8.670
 Why?
Chronic Pain
17
2024
177
5.910
 Why?
Opioid-Related Disorders
17
2024
400
4.070
 Why?
Drug Overdose
11
2024
163
3.890
 Why?
Medicaid
23
2021
264
2.730
 Why?
Drug Prescriptions
15
2024
102
2.640
 Why?
Tramadol
3
2024
30
2.400
 Why?
Alcoholism
4
2022
239
2.390
 Why?
Antipsychotic Agents
10
2018
235
1.950
 Why?
Retrospective Studies
45
2025
6607
1.800
 Why?
Anticoagulants
7
2025
270
1.730
 Why?
Adult
59
2025
14161
1.720
 Why?
Middle Aged
59
2025
13028
1.670
 Why?
United States
53
2024
5192
1.660
 Why?
Humans
112
2025
52483
1.580
 Why?
Osteoarthritis, Knee
3
2017
97
1.490
 Why?
Pain
11
2022
362
1.480
 Why?
Health Care Costs
10
2022
174
1.360
 Why?
Young Adult
29
2025
4329
1.340
 Why?
Female
74
2025
28171
1.330
 Why?
Adolescent
38
2024
6739
1.310
 Why?
Aged
44
2025
10121
1.300
 Why?
Male
70
2025
26761
1.290
 Why?
Atrial Fibrillation
4
2016
200
1.240
 Why?
Viscosupplements
3
2017
14
1.240
 Why?
Asthma
4
2017
316
1.210
 Why?
Hyaluronic Acid
3
2017
38
1.210
 Why?
Mental Disorders
7
2025
428
1.170
 Why?
Medication Adherence
6
2016
133
1.160
 Why?
Emergency Service, Hospital
6
2016
522
1.120
 Why?
Schizophrenia
5
2009
254
1.090
 Why?
Cross-Over Studies
2
2025
238
1.080
 Why?
Cohort Studies
17
2024
1542
1.050
 Why?
Arthroplasty, Replacement, Knee
4
2017
289
1.040
 Why?
Analgesics, Non-Narcotic
3
2012
117
1.030
 Why?
Substance-Related Disorders
5
2021
609
1.010
 Why?
Acetaminophen
4
2015
279
1.010
 Why?
Warfarin
4
2016
84
0.990
 Why?
Venous Thromboembolism
2
2025
77
0.980
 Why?
Patient Compliance
6
2009
230
0.980
 Why?
Veterans
10
2024
583
0.940
 Why?
Psychotropic Drugs
1
2025
77
0.900
 Why?
Psychotherapy
1
2025
113
0.870
 Why?
Suicide
1
2025
85
0.850
 Why?
Prescription Drugs
6
2014
41
0.840
 Why?
Cost-Benefit Analysis
5
2020
267
0.830
 Why?
Insurance, Health
7
2020
131
0.800
 Why?
Risk Factors
15
2025
3889
0.780
 Why?
Attention Deficit Disorder with Hyperactivity
1
2023
178
0.760
 Why?
Neck Pain
2
2021
10
0.750
 Why?
Back Pain
2
2021
39
0.740
 Why?
Arkansas
14
2024
2028
0.730
 Why?
Drug Utilization
11
2017
78
0.730
 Why?
Central Nervous System Stimulants
1
2023
206
0.730
 Why?
Arthralgia
1
2021
44
0.720
 Why?
Hospitalization
6
2016
736
0.710
 Why?
Professional-Patient Relations
1
2021
47
0.710
 Why?
Insurance, Pharmaceutical Services
2
2019
25
0.700
 Why?
Decision Support Techniques
3
2016
70
0.700
 Why?
Stroke
3
2016
512
0.690
 Why?
Logistic Models
8
2016
925
0.660
 Why?
Narcotic Antagonists
2
2024
139
0.660
 Why?
Naloxone
1
2020
79
0.640
 Why?
Breast Neoplasms
4
2023
1212
0.630
 Why?
Hydrocodone
3
2024
20
0.630
 Why?
Oxycodone
3
2024
26
0.620
 Why?
Legislation, Drug
1
2019
18
0.610
 Why?
Contraception
1
2019
29
0.600
 Why?
Proton Pump Inhibitors
2
2016
86
0.600
 Why?
Adrenal Cortex Hormones
2
2017
116
0.570
 Why?
Follow-Up Studies
8
2024
2279
0.560
 Why?
Guidelines as Topic
1
2018
111
0.560
 Why?
Mammography
1
2018
99
0.550
 Why?
Buprenorphine
3
2024
151
0.550
 Why?
Practice Guidelines as Topic
3
2017
488
0.540
 Why?
Histamine H2 Antagonists
1
2016
26
0.530
 Why?
Peptic Ulcer
1
2016
14
0.530
 Why?
Purinergic P2Y Receptor Antagonists
3
2022
29
0.510
 Why?
Education, Pharmacy, Graduate
1
2016
19
0.500
 Why?
Pyridones
1
2016
36
0.500
 Why?
Risk
4
2020
316
0.490
 Why?
Inappropriate Prescribing
1
2016
23
0.490
 Why?
Safety-Based Drug Withdrawals
1
2015
7
0.490
 Why?
Dextropropoxyphene
1
2015
6
0.490
 Why?
Insurance Claim Review
5
2010
40
0.490
 Why?
Health Expenditures
3
2011
72
0.490
 Why?
Tobacco Use Cessation
1
2015
10
0.480
 Why?
For-Profit Insurance Plans
1
2015
2
0.480
 Why?
Databases, Factual
11
2022
706
0.480
 Why?
Brain Ischemia
2
2016
161
0.480
 Why?
Pyrazoles
1
2016
114
0.470
 Why?
Mass Screening
1
2018
357
0.470
 Why?
Quinolines
1
2015
44
0.460
 Why?
Acetates
1
2015
52
0.460
 Why?
Time Factors
9
2018
2968
0.460
 Why?
Opiate Substitution Treatment
3
2024
102
0.460
 Why?
Stress, Psychological
1
2016
273
0.450
 Why?
Diabetic Neuropathies
1
2015
56
0.450
 Why?
Anticonvulsants
2
2006
134
0.450
 Why?
Insurance Claim Reporting
2
2011
11
0.450
 Why?
Low Back Pain
2
2025
31
0.450
 Why?
Critical Illness
1
2016
317
0.440
 Why?
Controlled Substances
2
2024
7
0.440
 Why?
Curriculum
2
2018
398
0.440
 Why?
Pain Management
1
2015
178
0.430
 Why?
Palliative Care
1
2016
214
0.420
 Why?
Tobacco Products
1
2015
127
0.420
 Why?
Aged, 80 and over
13
2023
3392
0.420
 Why?
Injections, Intra-Articular
3
2017
38
0.410
 Why?
Computers, Handheld
1
2013
25
0.410
 Why?
Prescription Drug Misuse
3
2024
33
0.410
 Why?
Neoplasms
1
2023
1325
0.410
 Why?
Evidence-Based Medicine
3
2014
261
0.400
 Why?
United States Department of Veterans Affairs
5
2024
293
0.390
 Why?
Neuralgia
2
2023
43
0.390
 Why?
Quality-Adjusted Life Years
3
2020
66
0.390
 Why?
Age Factors
6
2018
1132
0.390
 Why?
Benzodiazepines
3
2024
71
0.380
 Why?
Cross-Sectional Studies
6
2022
1678
0.380
 Why?
Health Knowledge, Attitudes, Practice
1
2015
509
0.360
 Why?
Case-Control Studies
7
2023
1201
0.360
 Why?
Community Pharmacy Services
3
2020
68
0.350
 Why?
Medicare
6
2023
274
0.340
 Why?
Health Personnel
1
2013
256
0.330
 Why?
Kidney Failure, Chronic
2
2022
210
0.320
 Why?
Employment
2
2015
93
0.320
 Why?
Age Distribution
5
2018
174
0.310
 Why?
Motor Vehicles
1
2009
14
0.310
 Why?
Antidepressive Agents
2
2009
177
0.310
 Why?
Propensity Score
3
2022
154
0.310
 Why?
Automobile Driving
1
2009
27
0.310
 Why?
Medication Errors
1
2009
25
0.310
 Why?
Pharmacists
3
2019
144
0.300
 Why?
Hemorrhage
3
2023
209
0.300
 Why?
Prevalence
5
2018
1006
0.290
 Why?
Cost of Illness
3
2013
121
0.290
 Why?
Physicians, Primary Care
2
2018
46
0.290
 Why?
Pain Measurement
6
2021
256
0.290
 Why?
Health Resources
2
2012
77
0.280
 Why?
College Admission Test
2
2018
13
0.280
 Why?
Antimanic Agents
1
2007
14
0.280
 Why?
School Admission Criteria
2
2018
35
0.270
 Why?
Schools, Pharmacy
2
2018
55
0.270
 Why?
Markov Chains
2
2020
30
0.270
 Why?
Georgia
6
2006
42
0.260
 Why?
Pharmaceutical Services
2
2018
52
0.260
 Why?
Constipation
1
2006
37
0.260
 Why?
Child
10
2019
7248
0.260
 Why?
Hypoglycemic Agents
1
2008
211
0.260
 Why?
Orthopedic Procedures
2
2017
71
0.260
 Why?
Overweight
1
2009
224
0.260
 Why?
Postoperative Complications
2
2025
1068
0.260
 Why?
Multivariate Analysis
4
2017
591
0.250
 Why?
Least-Squares Analysis
4
2011
44
0.250
 Why?
Platelet Aggregation Inhibitors
2
2021
181
0.250
 Why?
United States Food and Drug Administration
4
2011
98
0.250
 Why?
Knee Joint
2
2017
165
0.250
 Why?
Students, Pharmacy
2
2018
123
0.240
 Why?
Odds Ratio
4
2020
558
0.240
 Why?
Risperidone
2
2010
25
0.230
 Why?
Colectomy
1
2025
35
0.230
 Why?
North Carolina
5
2011
56
0.230
 Why?
Polypharmacy
1
2004
15
0.230
 Why?
Drug Costs
2
2020
39
0.220
 Why?
General Practitioners
1
2023
4
0.220
 Why?
Severity of Illness Index
3
2017
1026
0.220
 Why?
Patient Selection
1
2025
259
0.210
 Why?
Haloperidol
1
2003
46
0.210
 Why?
Renal Dialysis
2
2022
179
0.210
 Why?
Direct Service Costs
1
2003
5
0.210
 Why?
Motivation
1
2025
282
0.200
 Why?
Irritable Bowel Syndrome
1
2003
17
0.200
 Why?
Aftercare
1
2023
76
0.200
 Why?
Dose-Response Relationship, Drug
5
2014
1378
0.200
 Why?
Premedication
1
2002
18
0.200
 Why?
Health Services Needs and Demand
1
2004
159
0.190
 Why?
Diabetes Mellitus, Type 2
1
2008
560
0.190
 Why?
Common Cold
1
2002
5
0.190
 Why?
Bronchitis
1
2002
10
0.190
 Why?
Advisory Committees
3
2018
71
0.190
 Why?
Thromboembolism
1
2002
52
0.190
 Why?
Proportional Hazards Models
4
2017
443
0.190
 Why?
Accidents
1
2021
21
0.190
 Why?
Respiratory Insufficiency
1
2023
120
0.180
 Why?
Carcinoma, Non-Small-Cell Lung
1
2023
170
0.180
 Why?
Depressive Disorder, Major
2
2020
148
0.180
 Why?
Forecasting
3
2009
154
0.180
 Why?
Colorectal Neoplasms
1
2025
294
0.180
 Why?
Ambulatory Care Facilities
1
2002
124
0.180
 Why?
Mental Health Services
1
2004
212
0.180
 Why?
Delivery of Health Care
2
2021
323
0.170
 Why?
Respiratory Tract Infections
1
2002
87
0.170
 Why?
Patient Discharge
1
2023
330
0.170
 Why?
Interprofessional Relations
2
2018
90
0.170
 Why?
Afghan Campaign 2001-
2
2018
40
0.170
 Why?
Regression Analysis
5
2013
401
0.170
 Why?
Administration, Oral
2
2016
451
0.170
 Why?
Obesity
1
2009
1162
0.170
 Why?
Administration, Intranasal
1
2020
31
0.170
 Why?
Decision Making
5
2018
282
0.170
 Why?
Cardiovascular Diseases
2
2018
490
0.160
 Why?
Economics, Pharmaceutical
2
2009
6
0.160
 Why?
Brain Neoplasms
1
2023
291
0.160
 Why?
Selection Bias
2
2009
15
0.160
 Why?
Social Media
1
2022
117
0.160
 Why?
Comparative Effectiveness Research
2
2009
47
0.160
 Why?
Preventive Health Services
1
2020
52
0.160
 Why?
Coronary Restenosis
1
2019
32
0.150
 Why?
Guideline Adherence
3
2025
138
0.150
 Why?
Drug Administration Schedule
3
2011
374
0.150
 Why?
Child, Preschool
5
2011
4076
0.150
 Why?
Sepsis
1
2021
239
0.150
 Why?
Insurance Coverage
1
2020
115
0.150
 Why?
Health Care Surveys
2
2011
177
0.150
 Why?
Public Health Surveillance
1
2018
18
0.150
 Why?
Thiazoles
2
2016
55
0.150
 Why?
Sleep Deprivation
1
2018
19
0.150
 Why?
Papillomavirus Vaccines
1
2019
70
0.140
 Why?
Pharmacies
1
2019
62
0.140
 Why?
Physicians
1
2021
241
0.140
 Why?
Chronic Disease
5
2011
586
0.140
 Why?
Metabolic Diseases
1
2018
46
0.140
 Why?
Veterans Health
2
2014
63
0.140
 Why?
Molecular Weight
1
2017
82
0.140
 Why?
Acute Pain
1
2017
11
0.140
 Why?
Lung Neoplasms
1
2023
636
0.140
 Why?
Coronary Vessels
1
2019
166
0.140
 Why?
Papillomavirus Infections
1
2019
173
0.130
 Why?
Coronary Angiography
1
2019
367
0.130
 Why?
Fractional Flow Reserve, Myocardial
1
2019
127
0.130
 Why?
Educational Measurement
1
2018
196
0.130
 Why?
Treatment Outcome
7
2010
5422
0.130
 Why?
Eosinophils
1
2017
44
0.130
 Why?
Monte Carlo Method
1
2016
87
0.130
 Why?
Early Detection of Cancer
1
2018
189
0.130
 Why?
Chilaiditi Syndrome
1
2015
1
0.130
 Why?
Education, Pharmacy
1
2018
150
0.130
 Why?
Anti-Bacterial Agents
1
2002
807
0.120
 Why?
Incidental Findings
1
2015
43
0.120
 Why?
India
1
2015
68
0.120
 Why?
Health Services Accessibility
1
2020
436
0.120
 Why?
Geriatrics
1
2016
47
0.120
 Why?
Sex Distribution
1
2015
137
0.120
 Why?
Health Policy
3
2011
158
0.120
 Why?
Sulfides
1
2015
29
0.120
 Why?
Cyclopropanes
1
2015
27
0.120
 Why?
Models, Theoretical
1
2016
185
0.120
 Why?
Pyridines
1
2016
132
0.120
 Why?
Income
1
2015
102
0.120
 Why?
Thrombosis
1
2018
253
0.120
 Why?
Coronary Artery Disease
1
2019
294
0.120
 Why?
Renal Insufficiency, Chronic
1
2018
187
0.110
 Why?
Anti-Asthmatic Agents
1
2015
33
0.110
 Why?
Sarcopenia
1
2015
98
0.110
 Why?
Societies, Medical
1
2016
200
0.110
 Why?
Self Report
1
2016
210
0.110
 Why?
Long-Term Care
3
2012
51
0.110
 Why?
Educational Status
1
2015
226
0.110
 Why?
Enoxaparin
2
2025
31
0.110
 Why?
Disease Progression
1
2017
871
0.110
 Why?
California
2
2004
90
0.110
 Why?
Comorbidity
5
2017
625
0.110
 Why?
Health Literacy
1
2015
132
0.100
 Why?
Health Behavior
1
2015
257
0.100
 Why?
Prescriptions
2
2011
11
0.100
 Why?
Monitoring, Physiologic
1
2013
122
0.100
 Why?
Sensitivity and Specificity
1
2015
891
0.100
 Why?
Risk Assessment
2
2015
1327
0.100
 Why?
Drug Therapy, Combination
2
2004
395
0.100
 Why?
Managed Care Programs
1
2012
36
0.090
 Why?
Ticlopidine
1
2012
56
0.090
 Why?
Infant
3
2011
3733
0.090
 Why?
Predictive Value of Tests
2
2019
944
0.090
 Why?
Randomized Controlled Trials as Topic
2
2025
595
0.090
 Why?
Deductibles and Coinsurance
1
2011
2
0.090
 Why?
Hypertension, Pulmonary
1
2012
130
0.080
 Why?
Body Mass Index
2
2013
689
0.080
 Why?
Calibration
1
2009
57
0.080
 Why?
International Classification of Diseases
1
2009
67
0.080
 Why?
Clozapine
2
2010
25
0.080
 Why?
Analysis of Variance
1
2010
554
0.080
 Why?
Reference Values
1
2009
313
0.080
 Why?
Treatment Refusal
1
2009
35
0.080
 Why?
Carbamazepine
1
2007
13
0.070
 Why?
Lithium Compounds
1
2007
12
0.070
 Why?
Alendronate
1
2007
24
0.070
 Why?
Mental Health
1
2010
240
0.070
 Why?
Valproic Acid
1
2007
35
0.070
 Why?
Fractures, Spontaneous
1
2007
15
0.070
 Why?
Internationality
3
2014
43
0.070
 Why?
Osteoporosis, Postmenopausal
1
2007
29
0.070
 Why?
Chemotherapy, Adjuvant
1
2007
124
0.070
 Why?
Affect
1
2007
104
0.070
 Why?
Drug Labeling
1
2006
11
0.070
 Why?
Bone Density Conservation Agents
1
2007
75
0.060
 Why?
Data Collection
2
2009
290
0.060
 Why?
Adrenergic beta-Agonists
1
2005
42
0.060
 Why?
Self Disclosure
1
2005
12
0.060
 Why?
Australia
1
2025
89
0.060
 Why?
Multicenter Studies as Topic
1
2025
105
0.060
 Why?
Drug Interactions
2
2018
206
0.060
 Why?
Depression
1
2009
600
0.060
 Why?
Factor Analysis, Statistical
1
2004
86
0.060
 Why?
Eligibility Determination
1
2004
21
0.060
 Why?
Urban Population
1
2005
162
0.060
 Why?
Health Surveys
2
2018
238
0.060
 Why?
Prescription Fees
1
2004
14
0.050
 Why?
Length of Stay
1
2007
663
0.050
 Why?
Algorithms
1
2007
672
0.050
 Why?
Laparoscopy
1
2025
180
0.050
 Why?
Data Interpretation, Statistical
3
2009
164
0.050
 Why?
MEDLINE
1
2002
8
0.050
 Why?
SEER Program
1
2023
103
0.050
 Why?
Prospective Studies
1
2008
2481
0.050
 Why?
Cognition Disorders
1
2003
196
0.050
 Why?
Antidepressive Agents, Second-Generation
1
2002
27
0.050
 Why?
Quality of Life
2
2023
879
0.050
 Why?
Neuropsychological Tests
1
2003
338
0.050
 Why?
Analgesics
1
2023
107
0.050
 Why?
Pharmacy
2
2018
55
0.050
 Why?
Gastrointestinal Hemorrhage
1
2022
89
0.050
 Why?
Longitudinal Studies
2
2014
747
0.040
 Why?
Patient Protection and Affordable Care Act
1
2020
52
0.040
 Why?
Needs Assessment
1
2020
140
0.040
 Why?
Myocardial Revascularization
1
2019
21
0.040
 Why?
Ohio
1
2019
45
0.040
 Why?
Quality of Health Care
1
2020
187
0.040
 Why?
Incidence
2
2014
1062
0.040
 Why?
Pharmacoepidemiology
1
2017
8
0.030
 Why?
Universities
1
2018
175
0.030
 Why?
Research Design
2
2014
359
0.030
 Why?
Vaccination
1
2019
298
0.030
 Why?
Pilot Projects
1
2019
721
0.030
 Why?
Communication
1
2018
257
0.030
 Why?
Qualitative Research
1
2018
364
0.030
 Why?
Electronic Health Records
1
2018
268
0.030
 Why?
Attitude of Health Personnel
1
2018
360
0.030
 Why?
Ischemic Attack, Transient
1
2013
57
0.030
 Why?
Survival Analysis
1
2014
673
0.030
 Why?
Lipids
1
2013
155
0.020
 Why?
Linear Models
1
2013
287
0.020
 Why?
Diagnosis, Dual (Psychiatry)
1
2012
41
0.020
 Why?
Stress Disorders, Post-Traumatic
1
2017
403
0.020
 Why?
Diagnostic Tests, Routine
1
2012
31
0.020
 Why?
Cost Control
1
2011
13
0.020
 Why?
Acute Coronary Syndrome
1
2012
80
0.020
 Why?
Blood Pressure
1
2013
537
0.020
 Why?
Blood Glucose
1
2013
473
0.020
 Why?
Reproducibility of Results
2
2005
1229
0.020
 Why?
Dibenzothiazepines
1
2010
10
0.020
 Why?
Adolescent Behavior
1
2011
106
0.020
 Why?
Hypnotics and Sedatives
1
2010
72
0.020
 Why?
Off-Label Use
1
2010
24
0.020
 Why?
Observation
1
2009
8
0.020
 Why?
Epidemiologic Methods
1
2009
46
0.020
 Why?
Causality
1
2009
53
0.020
 Why?
Diabetes Mellitus
1
2013
316
0.020
 Why?
Mood Disorders
1
2009
59
0.020
 Why?
Quinolones
1
2010
50
0.020
 Why?
Anxiety Disorders
1
2009
130
0.020
 Why?
Piperazines
1
2010
118
0.020
 Why?
ROC Curve
1
2009
253
0.020
 Why?
Headache
1
2008
76
0.020
 Why?
Sex Factors
1
2009
727
0.020
 Why?
Confidence Intervals
1
2007
158
0.020
 Why?
Probability
1
2007
172
0.020
 Why?
Drug Utilization Review
1
2005
22
0.010
 Why?
Drug Monitoring
1
2005
83
0.010
 Why?
Bone Density
1
2007
399
0.010
 Why?
Registries
1
2007
581
0.010
 Why?
Health Maintenance Organizations
1
2002
16
0.010
 Why?
Antidepressive Agents, Tricyclic
1
2002
28
0.010
 Why?
Costs and Cost Analysis
1
2002
95
0.010
 Why?
Martin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (373) concept(s)
_
Co-Authors Expand Description
See all (54) people
_
Similar People Expand Description
See all (37) people
_
Same Department Expand Description
Search Department